Withdrawing and withholding life-support therapy in patients who are unlikely to survive despite treatment are common practices in intensive care units (ICUs). The literature suggests there is a large variation in practice between different ICUs in different parts of the world. We conducted a postal survey among all public ICUs in New Zealand to investigate the pattern of practice in withholding and withdrawal of therapy. Nineteen ICUs responded to this survey and they represented 74% of all the public ICU beds and 83% of the annual ICU admissions. The percentage of ICU admissions with therapy withdrawn or withheld was less than 10% in most ICUs. Only a small percentage (21%) of ICUs had a formal policy in withholding and withdrawal of therapy. The timing of making the decision to withhold or withdraw therapy was very variable. The patient and/or the family, the primary medical team consultant, two or more ICU consultants, and ICU nurses were usually involved in the decision making process. ICU nurses were more commonly involved in the decision making process in smaller ICUs (5 beds vs 10 beds, P=0.03). The patient's pre-ICU quality of life, medical comorbidities, predicted mortality, predicted post-ICU quality of life, and the family's wishes were important factors in deciding whether ICU therapy would be withheld or withdrawn. Hospice ward or the patient's home was the preferred place for palliative care in 32% of the responses.
Withholding ICU life-support therapy when treatment is unlikely to be effective and withdrawing ICU therapy when the patients are not responding are common practices in intensive care units (ICUs). The literature suggests there is a large variation in the pattern of practice in different ICUs in different parts of the world [1] [2] [3] [4] [5] . A retrospective cohort study in our ICU showed that withholding or withdrawing therapy occurred in 20% of patients with acute renal impairment, and the decision to withdraw or to withhold was made earlier than in some other ICUs 6 . Epidemiological data in this area of practice from Australasian ICUs are scarce 7 . We aimed to investigate the pattern of practice in withholding and withdrawing lifesupport therapy in all public ICUs in New Zealand.
MATERIALS AND METHODS
This was a cross-sectional descriptive study. According to the Australian and New Zealand Intensive Care Society (ANZICS) review of intensive care resources and activity database 2001/2002, there were two private ICUs, 25 public adult and paediatric ICUs, 168 ventilated ICU beds, 13055 annual ICU admissions and 3748 HDU admissions to public ICUs in New Zealand in 2002 8 . Public ICUs for this survey were identified by this database. Neonatal ICUs, private ICUs, and three public ICUs that have no nominated clinical director were not included in this survey. After obtaining approval from the Ethics Committee of North Shore Hospital in Auckland, anonymous questionnaires (Appendix 1) were sent to clinical directors of 22 public New Zealand ICUs in January 2004 to evaluate the pattern of practice in withholding and withdrawal of life-support therapy in their ICUs. The public ICU annual admission and ventilated bed data from the ANZICS resource database were used as denominators for calculations of representation rates of this survey. Coronary care admissions to a combined coronary care and inten-sive care area or high dependency admissions to a separate high dependency area were excluded from further analysis in this survey. The questionnaire aimed to evaluate the demographic data of the ICU, the decision-making process, the usual and preferred place for palliative care, and the way ICU nurses were involved in this area of practice. If the ICU clinical director did not respond to the first questionnaire in 12 weeks and the reminder in four weeks, they were regarded as non-respondents. All ICUs surveyed are listed in Appendix 2. The relationship between categorical outcome variables was tested by Chi-square or Fisher exact test. Continuous outcome variables that were not normally distributed were tested by the Mann-Whitney test. All tests were two-tailed test unless stated otherwise, and P value less than 0.05 was regarded as significant.
RESULTS
Nineteen out of 22 ICUs (86%) responded to this survey. The total number of ventilated beds and ICU admissions of these 19 ICUs in 2003 were 124 and 12078 respectively, and they represented about 74% of the total public ICU beds and 83% of the public ICU annual admissions in New Zealand. The demographic data of the ICUs are described in Table 1 .
Less than 10% of the ICU admissions had therapy withheld or withdrawn in 68% of the ICUs. Only three ICUs could provide data regarding the percentage of ICU deaths that had therapy withdrawn or withheld, and it ranged from 54% to 68%. About 21% of the ICUs had a formal policy in withholding and withdrawal of life-support therapy. The timing of making the decision to withhold or withdraw therapy was very variable. Setting certain degrees of limitation in therapy before ICU admission in selected patients as part of the ICU treatment plan was reported by 63% of the ICUs. High predicted mortality, medical comorbidities, and quality of life (before and after ICU care) were the most important factors in the decision making. The personnel and factors usually involved in the decision-making process are listed in Table 2 .
ICU nurses were more commonly involved in the decision-making process in smaller ICUs (5 beds vs 10 beds, P=0.03), and ICUs with lower numbers of admissions per year (496 vs 939 admissions, P=0.04) ( Tables 3 and 4) .
A third of the clinical directors would prefer hospice ward or patient's home for palliative care but in practice, ICU or general ward was the usual place where palliative care was offered. The reasons were mainly related to the environment, ICU bed availability, the degree of nursing care required and the patient's family wishes.
DISCUSSION
There is a large variation in the frequency and pattern of practice in withholding and withdrawing lifesupport therapy in different countries [1] [2] [3] [4] [5] . Our results showed that there were similarities and differences between public New Zealand ICUs and other reports. High predicted mortality, medical comorbidities, and poor quality of life (before and after ICU care) were most important factors in the decision to withhold or withdraw therapy in public New Zealand ICUs, very similar to results of the surveys from England, Netherlands, U.S.A. and France [9] [10] [11] . Most public New Zealand ICU directors did not consider resources and ICU bed availability as important in the decision-making process. The timing of making such decisions was very variable, but setting certain limitations in therapy for patients with severe comorbidities and poor quality of life before ICU admission were common practices in public New Zealand ICUs. This pattern of practice was not observed in the literature [12] [13] [14] , and may account for the large percentage of ICU admissions (e.g. 10 to 30%) with therapy withheld in four public New Zealand ICUs. Patients and/or their families and ICU nurses were commonly involved in the decision-making process in public New Zealand ICUs, in contrast to results of the surveys from Italy, France, Portugal and Switzerland [15] [16] [17] . Ethics committee consultations are increasingly being used to resolve conflicts about life-sustaining interventions in U.S.A. but none of the responses in this survey mentioned the use of ethics consultations 18 . The exact reasons for the differences in practice between New Zealand ICUs and other reports remain unknown although cultural differences have been suggested to account for the differences amongst European countries [19] [20] .
Most critically ill patients died in the ICUs or general ward after life-support therapy was withdrawn. However, a significant percentage of the ICU clinical directors (32%) would prefer alternative settings for palliative care if resources allowed. People often prefer to die at home in familiar and comfortable surroundings, with friends and family nearby [21] [22] . Hospice wards provide a more peaceful environment for dying patients and their families and with the nursing support that may be required 23 . However, an in-patient hospice unit is not closely located with the ICU in public New Zealand hospitals, and this may explain why most critically ill patients died in the ICU or general ward instead of the hospice ward. Restructuring hospital care with closer collaboration between the two services may provide a potential solution to overcome the dichotomy between hospice and intensive care for dying patients 24 .
There are significant limitations with this study. First, all responses to this survey were voluntary and self-reported. Biases created by subjective perceptions of own practices were likely. Second, we only directed the questionnaires to the clinical directors of ICUs. There were 51 full-time specialists working in public New Zealand ICUs in 2002 8 . The 19 clinical directors represented only 37% of the ICU specialists working in New Zealand and might not accurately represent the opinions of all members of the ICU team. The difference in perceptions between ICU doctors and nurses has been highlighted in the literature 17 . Furthermore, private ICUs and public ICUs without a nominated clinical director were not included in this survey. The pattern of practice in private ICUs is expected to differ from the public ICUs. Finally, many areas of withholding and withdrawing life-support therapy in ICUs were not studied in this study. Only three ICUs provided exact data regarding the percentage of ICU mortality with therapy withdrawn or withheld. Prospective data collection in this area of ICU practice could provide useful information for internal and nationwide clinical audits but was lacking when this survey was done.
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